Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells

International Journal of Oncology

Volumn 44, Issue 3, 2014, Pages 637-646

  Park, Sae Hyun ^a   Song, Ji Ye ^b   Kim, Yu Kyung ^b   Heo, Jin Hyung ^b   Kang, Haeyoun ^b   Kim, Gwangil ^b   An, Hee Jung ^b   Kim, Tae Hoen ^b  

^a CHA Gangnam Medical Center   (South Korea)

^b CHA University   (South Korea)

Author keywords

Fascin1; High grade serous ovarian carcinoma; Prognosis

Indexed keywords

BETA CATENIN; CARBOPLATIN; CISPLATIN; FASCIN1; PACLITAXEL; SMALL INTERFERING RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HIGH GRADE SEROUS OVARY CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MIDDLE AGED; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR INVASION; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT;

AGED; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTADENOCARCINOMA, SEROUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896699654     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2232     Document Type: Article

References (30)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
2. Park B, Park S, Kim TJ, et al: Epidemiological characteristics of ovarian cancer in Korea. J Gynecol Oncol 21: 241-247, 2010.
3. Hashimoto Y, Skacel M and Adams JC: Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 37: 1787-1804, 2005. (Pubitemid 40961664)
4. Vignjevic D, Kojima S, Aratyn Y, Danciu O, Svitkina T and Borisy GG: Role of fascin in filopodial protrusion. J Cell Biol 174: 863-875, 2006. (Pubitemid 44373735)
5. Li A, Dawson JC, Forero-Vargas M, et al: The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion. Curr Biol 20: 339-345, 2010.
6. Kureishy N, Sapountzi V, Prag S, Anilkumar N and Adams JC: Fascins, and their roles in cell structure and function. Bioessays 24: 350-361, 2002. (Pubitemid 34305690)
7. Pelosi G, Pastorino U, Pasini F, et al: Independent prognostic value of fascin immunoreactivity in stage I non-small cell lung cancer. Br J Cancer 88: 537-547, 2003. (Pubitemid 36363363)
8. Zhang H, Xu L, Xiao D, et al: Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 59: 958-964, 2006. (Pubitemid 44422851)
9. Yoder BJ, Tso E, Skacel M, et al: The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 11: 186-192, 2005. (Pubitemid 40075794)
10. Hashimoto Y, Skacel M, Lavery IC, Mukherjee AL, Casey G and Adams JC: Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer 6: 241, 2006.
11. Tong GX, Yee H, Chiriboga L, Hernandez O and Waisman J: Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol 36: 741-746, 2005. (Pubitemid 41112028)
12. Kabukcuoglu S, Oner U, Ozalp SS, Bildirici K, Yalcin OT and Colak E: The role of actin bundling protein fascin in the progression of ovarian neoplasms. Eur J Gynaecol Oncol 27: 171-176, 2006.
13. Tao YS, Edwards RA, Tubb B, Wang S, Bryan J and McCrea PD: beta-catenin associates with the actin-bundling protein fascin in a noncadherin complex. J Cell Biol 134: 1271-1281, 1996. (Pubitemid 26300171)
14. Lee CM, Shvartsman H, Deavers MT, et al: beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma. Gynecol Oncol 88: 363-368, 2003. (Pubitemid 36331991)
15. Hashimoto Y, Parsons M and Adams JC: Dual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasis. Mol Biol Cell 18: 4591-4602, 2007. (Pubitemid 350060184)
16. Vignjevic D, Schoumacher M, Gavert N, et al: Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 67: 6844-6853, 2007. (Pubitemid 47105531)
17. Hashimoto Y, Ito T, Inoue H, et al: Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 11: 2597-2605, 2005. (Pubitemid 40569459)
18. Machesky LM and Li A: Fascin: Invasive filopodia promoting metastasis. Commun Integr Biol 3: 263-270, 2010.
19. Kabukcuoglu S, Ozalp SS, Oner U, et al: Actin bundling protein fascin expression in ovarian neoplasms: comparison of histopathologic features of tumors obtained by the first and secondary cytoreduction surgeries. Eur J Gynaecol Oncol 27: 123-128, 2006.
20. Cho EY, Choi Y, Chae SW, Sohn JH and Ahn GH: Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms. Pathol Int 56: 62-70, 2006.
21. Wen YH, Yee H, Goswami S and Shukla PS: Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy. Int J Gynecol Pathol 28: 187-192, 2009.
22. Daponte A, Kostopoulou E, Papandreou CN, et al: Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancer. Anticancer Res 28: 1905-1910, 2008. (Pubitemid 351892904)
23. Hashimoto Y, Loftis DW and Adams JC: Fascin-1 promoter activity is regulated by CREB and the aryl hydrocarbon receptor in human carcinoma cells. PLoS One 4: e5130, 2009.
24. Clevers H and Nusse R: Wnt/beta-catenin signaling and disease. Cell 149: 1192-1205, 2012.
25. Jawhari AU, Buda A, Jenkins M, et al: Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 162: 69-80, 2003. (Pubitemid 36041990)
26. Gamallo C, Palacios J, Moreno G, Calvo de Mora J, Suarez A and Armas A: beta-catenin expression pattern in stage I and II ovarian carcinomas: relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol 155: 527-536, 1999. (Pubitemid 29370402)
27. Kildal W, Risberg B, Abeler VM, et al: beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients. Eur J Cancer 41: 1127-1134, 2005. (Pubitemid 40725570)
28. Xie JJ, Xu LY, Zhang HH, et al: Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun 337: 355-362, 2005. (Pubitemid 41393802)
29. Hu W, McCrea PD, Deavers M, Kavanagh JJ, Kudelka AP and Verschraegen CF: Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 18: 83-88, 2000. (Pubitemid 32096054)
30. Chen L, Yang S, Jakoncic J, Zhang JJ and Huang XY: Migrastatin analogues target fascin to block tumour metastasis. Nature 464: 1062-1066, 2010.